SCHEMBL17469509

SCHEMBL17469509

CNCCN(C)Cc1n[nH]c2ccc(Oc3ccc(OC)cc3)cc12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT1 Q99873 4/20 0.43
▸ HTR2A P28223 4/20 0.39
▸ HTR2C P28335 3/20 0.36
▸ HTR2B P41595 3/20 0.36
▸ HTR6 P50406 3/20 0.36
▸ PRKAG1 P54619 1/20 0.35
▸ PRKAA1 Q13131 1/20 0.35
▸ PRKAB1 Q9Y478 1/20 0.35
▸ FADS1 O60427 1/20 0.35
▸ PRMT5 O14744 1/20 0.35
▸ WDR77 Q9BQA1 1/20 0.35
▸ HSP90AA1 P07900 1/20 0.35
▸ HSP90AB1 P08238 1/20 0.35
▸ GSK3B P49841 2/20 0.34
▸ HTR1A P08908 2/20 0.34
▸ HTR1D P28221 2/20 0.34
▸ HTR1E P28566 2/20 0.34
▸ HTR7 P34969 2/20 0.34
▸ HTR5A P47898 2/20 0.34
▸ HTR3E A5X5Y0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17469504 0.93 HTR2A (0.44) PRMT1HTR2AHTR2CHTR2BHTR6
SCHEMBL17469445 0.93 FADS1 (0.40) PRMT1HTR2AHTR2CHTR2BHTR6
SCHEMBL17469449 0.91 PRMT1 (0.37) PRMT1HTR2APRMT5WDR77HSP90AA1
SCHEMBL16120045 0.91 TTK (0.39) PRMT1HTR6HTR1DHTR1B
SCHEMBL17469497 0.90 PRMT1 (0.38) PRMT1HTR2AFADS1PRMT5WDR77
SCHEMBL17469503 0.88 PRMT1 (0.46) PRMT1
SCHEMBL17469508 0.87 PRMT1 (0.41) PRMT1GSK3BMTNR1AMTNR1BSLC6A2
SCHEMBL17469502 0.87 LRRK2 (0.40) PRMT5WDR77
SCHEMBL17469469 0.87 PRMT5 (0.37) PRMT1HTR6PRMT5WDR77L3MBTL1
SCHEMBL17469470 0.86 HSP90AA1 (0.37) PRMT1HSP90AA1HSP90AB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180105497-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2018-04-19 — — US disclosed
US-9765035-B2 Arginine methyltransferase inhibitors and uses thereof Epizyme, Inc. (US) 2017-09-19 — — US disclosed
US-20160024017-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2016-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024017-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 PRMT1 1/4885HTR2A 4184/4885HTR2C 4427/4885
US-20180105497-A1 ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF PRMT1, PRMT3, PRMT5 PRMT1 1/4885HTR2A 4184/4885HTR2C 4427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback